ABC Safe Drug Act

Hozzl · 2025-05-09T12:45:58Z

Explore the details of Senate Bill 1407 ABC Safe Drug Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

5/9/2025, 12:45 PM

Summary of Bill S 1407

The ABC Safe Drug Act, introduced in the 119th session of Congress under bill number S.1407 on April 10, 2025, aims to address drug safety issues. The bill has key provisions related to enhancing drug monitoring protocols, improving adverse event reporting systems, and strengthening oversight of the pharmaceutical industry. Specific directives in the bill may include requirements for increased transparency in drug labeling, stricter penalties for non-compliance with safety regulations, and mechanisms to better protect consumers from unsafe medications. For more details, the official PDF version of the bill can be accessed via the provided link.

Congressional Summary of S 1407

Anyone But China Safe Drug Act or the ABC Safe Drug Act

This bill restricts federal health care programs from purchasing drugs with active ingredients manufactured in China and provides tax incentives for the purchase of certain pharmaceutical and device manufacturing property for use in the United States.

The bill phases in restrictions on federal health care programs’ purchase of drugs. By January 1, 2030, federal health care programs may not purchase any drug that contains active ingredients from China or countries that do not meet the health and safety standards of the Food and Drug Administration. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement; this waiver authority expires in 2031.

The bill also requires all drugs to be labeled with the country of origin of each active ingredient in the drug. Drugs that are not labeled with this information are deemed misbranded.

Finally, the bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2025 and 2030. Qualified pharmaceutical and medical device manufacturing property is any tangible property placed in service in the United States as part of the construction or expansion of property for the manufacture of drugs or devices.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 1407

Bill S 1407 is currently in the status of Bill Introduced since April 10, 2025. Bill S 1407 was introduced during Congress 119 and was introduced to the Senate on April 10, 2025. Bill S 1407's most recent activity was Read twice and referred to the Committee on Finance. as of April 10, 2025